Travere Therapeutics (NASDAQ:TVTX – Get Free Report) was downgraded by stock analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a note issued to investors on Friday, FlyOnTheWall reports. Several other equities analysts have also commented on the stock. HC Wainwright lowered their price objective on shares of […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) fell 4.4% during trading on Monday . The stock traded as low as $13.77 and last traded at $13.77. 140,819 shares traded hands during trading, a decline of 89% from the average session volume of 1,292,207 shares. The stock had previously closed at $14.41. Analysts Set New […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) was the target of some unusual options trading activity on Friday. Traders acquired 6,165 call options on the stock. This is an increase of approximately 1,393% compared to the typical volume of 413 call options. Wall Street Analysts Forecast Growth A number of research firms have issued […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q1 2022 earnings estimates for shares of Travere Therapeutics in a research note issued to investors on Monday, April 25th. Jefferies Financial Group analyst M. Raycroft anticipates that the company will earn ($0.63) per share for the quarter. Jefferies […]